Ting-Wan Lin
Company: GenomeFrontier
Job title: BD/PM Director
Seminars:
Preclinical Case Study: GF-CART01: Armoured CD19/CD20 Dual Targeting Non-Viral CAR T Therapy for B Cell Malignancy 12:00 pm
To view full session details, download the agenda hereRead more
day: Conference Day One